Back to top
more

Johnson & Johnson (JNJ)

(Delayed Data from NYSE)

$271.19 USD

271.19
6,034,405

+5.34 (2.01%)

Updated Sep 1, 2026 04:00 PM ET

After-Market: $271.76 +0.57 (0.21%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (97 out of 248)

Industry: Large Cap Pharmaceuticals

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Aparajita Dutta headshot

Pharma ETFs in Spotlight Following Robust Q3 Earnings Results

by Aparajita Dutta

Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.

Zacks Equity Research

Why Is Johnson & Johnson (JNJ) Up 1.7% Since Last Earnings Report?

by Zacks Equity Research

Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Aparajita Dutta headshot

Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month

by Aparajita Dutta

As National Alzheimer's Awareness Month spotlights new treatments, healthcare ETFs like XLV and VHT might gain fresh investor appeal.

Zacks Equity Research

Bayer Q3 Earnings Beat Estimates on Crop Science Business Gains

by Zacks Equity Research

Bayer's Q3 earnings surged on Crop Science strength, offsetting pricing and currency headwinds across divisions.

Sundeep Ganoria headshot

How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?

by Sundeep Ganoria

ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new market share gains.

Kinjel Shah headshot

J&J's MedTech Unit Sales Improve: Will the Momentum Last?

by Kinjel Shah

J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.

Zacks Equity Research

Wall Street Analysts See Johnson & Johnson (JNJ) as a Buy: Should You Invest?

by Zacks Equity Research

The average brokerage recommendation (ABR) for Johnson & Johnson (JNJ) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks Equity Research

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Equity Research

Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View

by Zacks Equity Research

HALO posts strong third-quarter results with earnings and revenues topping estimates and raises 2025 guidance on robust royalty growth.

Kinjel Shah headshot

J&J's Innovative Medicines Unit Shows Resilience Amid Stelara LOE

by Kinjel Shah

JNJ's Innovative Medicine unit posts its second straight quarter of more than $15B in sales, driven by Darzalex, Tremfya and Erleada despite Stelara's LOE hit.